Tang, Sunny X. http://orcid.org/0000-0002-4001-8120
Hänsel, Katrin
Oliver, Lindsay D. http://orcid.org/0000-0003-2163-7257
Dickie, Erin W. http://orcid.org/0000-0003-3028-9864
Hawco, Colin
John, Majnu
Voineskos, Aristotle http://orcid.org/0000-0003-0156-0395
Gold, James M.
Buchanan, Robert W.
Malhotra, Anil K.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH102318, R01MH102324, K23 MH130750-01)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 12 October 2023
Accepted: 11 June 2024
First Online: 24 June 2024
Competing interests
: S.X.T. owns equity and serves as a consultant for North Shore Therapeutics, received research funding and serves as a consultant for Winterlight Labs, and is on the advisory board and owns equity for Psyrin. R.W.B. is a DSMB member for Merck, Newron, and Roche; on the advisory board for Acadia, Karuna, Merck, Neurocrine, and Roche; and a consultant for Boehringer Ingelheim GMBH. A.K.M. is a consultant for Acadia Pharmaceuticals, Genomind Inc., Informed DNA, and Janssen Pharmaceuticals. The remaining authors declare no competing interests.